For Some, Anti-VEFG Treatment Preserves Sight for a Lifetime For Some, Anti-VEFG Treatment Preserves Sight for a Lifetime

Nearly 20% of those who received anti-VEGF treatment for neovascular age-related macular degeneration (nAMD) retained useful visual acuity over their lifetime, a new study finds.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Ophthalmology News Source Type: news